Clindamycin
Product Images NDC 71872-7123

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 71872-7123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (7123)

Label for Clindamycin Injection, USP, 900 mg/6 mL (150 mg/mL) single-dose Fliptop vial. The label includes usage directions for IM or IV use, warnings to dilute before IV use, and storage instructions at 20 to 25°C (68 to 77°F). It mentions preservatives and pH adjustment details. Manufactured for Alvogen, Inc. and repackaged and distributed by Medical Purchasing Solutions, LLC, Scottsdale, AZ.*

FDA Label Image

Label-900 (Label 900)

Clindamycin Injection, USP 900 mg/6 mL (150 mg/mL) single-dose vial label. The label specifies use for intramuscular or intravenous administration, includes a warning for intravenous use, and notes the product is Rx only. Alvogen, Inc. is listed as the manufacturer. The label also shows the NDC 47781-461-68 and a revision date of August 2015.*

FDA Label Image

Structure (Structure)

Chemical structure of clindamycin, showing its molecular configuration including a methylated amine group, hydroxyl groups, and a phosphorus-containing moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.